Company news
Genovis AB news in 2026
Genovis AB's news releases, calls and decks from 2026, newest first.
Genovis AB Interim report January - June 2026
July 23, 2026
Genovis Launches AlligBAITOR™ and Strengthens Its Offering in Advanced Protein Analytics
June 26, 2026
Genovis Acquires KPL — Expanding Its Enzyme Platform with a Proprietary Portfolio of Precision Proteases for Protein Analysis
June 1, 2026
Communiqué from Genovis AB (publ) Annual General Meeting May 18, 2026
May 18, 2026
Genovis Announces Change in Chief Financial Officer Position
May 12, 2026
Genovis AB Interim Report January-March 2026
April 28, 2026
Genovis AB publishes Annual Report 2025
April 23, 2026
The board of directorsʼ proposal (genovis agm 2026 boarda proposals)
April 15, 2026
Proxy form (genovis agm 2026 proxy form)
April 15, 2026
Notice of AGM (genovis agm 2026 notice)
April 15, 2026
Genovis Enters Non-Exclusive License Agreement for EndoS2 Enzyme Technology for Antibody-Drug Conjugate (ADC) Development and Commercialization
March 25, 2026
Nomination committee proposal (genovis agm 2026 nomination committee proposal)
March 11, 2026
Genovis AB Year-end Report January-December 2025
February 12, 2026